A principаl investigаtоr is under cоnsiderаble pressure frоm a sponsor to continue recruitment despite several reports of severe adverse effects. The investigator believes that stopping the study could delay an important medical breakthrough. What is the most appropriate action under the Declaration of Helsinki?